Evidence map›Paper›PMID 37291278›Full record

ArticleNature reviews. Gastroenterology & hepatology2023

Measuring NAFLD models of care.

Alina M Allen, Zobair M Younossi, Emmanuel A Tsochatzis, William Alazawi, Shira Zelber-Sagi, Juan Pablo Arab, Kenneth Cusi, Jeffrey V Lazarus

Abstract read
PubMed Publisher
In one paragraph

Article in Nature reviews. Gastroenterology & hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Envisioning how to advance the MASH field.Nature reviews. Gastroenterology & hepatology · 2024
    Review
  6. Making Sense of the Nonalcoholic Fatty Liver Disease Clinical Practice Guidelines: What Clinicians Need to Know.Diabetes spectrum : a publication of the American Diabetes Association · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alina M AllenDivision of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Zobair M YounossiCenter for Liver Disease, Inova, Falls Church, VA, USA.
Emmanuel A TsochatzisUCL Institute for Liver and Digestive Health, Royal Free Hospital, London, UK.ORCID http://orcid.org/0000-0001-5069-2461
William AlazawiBarts Liver Centre, Blizard Institute, Queen Mary University of London, London, UK.
Shira Zelber-SagiSchool of Public Health, Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa, Israel.
Juan Pablo ArabDivision of Gastroenterology, Department of Medicine, Schulich School of Medicine, Western University & London Health Sciences Centre, London, Ontario, Canada.ORCID http://orcid.org/0000-0002-8561-396X
Kenneth CusiDivision of Endocrinology, Diabetes & Metabolism, Department of Medicine, University of Florida, Gainesville, FL, USA.ORCID http://orcid.org/0000-0002-8629-418X
Jeffrey V LazarusCUNY Graduate School of Public Health and Health Policy (CUNY SPH), New York, NY, USA. Jeffrey.Lazarus@sph.cuny.edu.ORCID http://orcid.org/0000-0001-9618-2299

Funding

Medical Research Council MR/T031883/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Non-alcoholic Fatty Liver DiseaseHumansLiver CirrhosisRisk Factors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.